Novartis AG is 52.7x more valuable than Cogent Biosciences, Inc. by market capitalization ($282.64 B vs $5.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COGT | NVS |
|---|---|---|
| Market cap | $5.36 B | $282.64 B |
| US-listed rank | #1334 | #47 |
| Revenue (latest FY) | $7.87M | - |
| Net income (latest FY) | -$328.94M | - |
| Net margin | -4179.1% | - |
| SEC filings | 595 | 947 |
Novartis AG is 52.7x more valuable than Cogent Biosciences, Inc. by market capitalization ($282.64 B vs $5.36 B).
Full pages: Cogent Biosciences, Inc. and Novartis AG, or browse the full rankings.